Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The aim of the present study was to investigate the potential clinical application of the genetic marker microRNA (miRNA)-210 in the cerebrospinal fluid (CSF) and serum of patients with Alzheimer's disease (AD). The enrolled patients were divided into the mild cognitive impairment (MCI) and AD groups. Healthy individuals were used as the controls. The mRNA and protein expression of vascular endothelial growth factor (VEGF) in the CSF and serum samples was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analysis, respectively. The expression of miRNA-210 in the CSF and serum was detected by RT-qPCR. The results revealed that the mRNA and protein expression levels of VEGF in the CSF and serum were decreased in the MCI and AD groups compared with those in the control group. The greater the severity of the dementia, the lower the mRNA and protein expression of VEGF. Similar to the trend observed for VEGF, the miRNA-210 expression in the CSF and serum decreased as the severity of the AD increased. miRNA-210 is thus not only indicative of AD pathogenesis, but may also provide novel insights into the prevention and treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pikula, A., Beiser, A. S., Chen, T. C., Preis, S. R., Vorgias, D., DeCarli, C., Au, R., Kelly-Hayes, M., Kase, C. S., Wolf, P. A., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001447 · Cited by 200 · cited 1×
“Furthermore, it has been demonstrated that, when brain lesions are severe, VEGF can enter the blood circulation from the brain due to the rupture of nerve cells (15).”
Cited by
Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
Swarbrick, S., Wragg, N., Ghosh, S., & Stolzing, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1500-y · Cited by 350
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
van den Berg, M. M. J., Krauskopf, J., Ramaekers, J. G., Kleinjans, J. C. S., Prickaerts, J., & Briedé, J. J. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101732 · Cited by 253
Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
Takousis, P., Sadlon, A., Schulz, J., Wohlers, I., Dobricic, V., Middleton, L., Lill, C. M., Perneczky, R., & Bertram, L. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4952 · Cited by 173
Luo, R., Wang, Y., Xu, P., Cao, G., Zhao, Y., Shao, X., Li, Y.-X., Chang, C., Peng, C., & Wang, Y.-L. (2016) · Scientific Reports · doi:10.1038/srep19588 · Cited by 100
Self-citationA Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease
Herrera-Espejo, S., Santos-Zorrozua, B., Álvarez-González, P., Lopez-Lopez, E., & Garcia-Orad, Á. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01676-9 · Cited by 81
Metadata
- Authors
- ZHU, Y., LI, C., SUN, A., WANG, Y., & ZHOU, S.
- Venue
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos Publications
- Published
- 2015-01-14
- Volume
- 9
- Issue
- 3
- Pages
- 1013-1017
- ISSN
- 1792-0981 (ISSN-L)
- 1792-1015
- OpenAlex
- W2066945106
- Cited by
- 53
- References
- 1
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease. https://app.cochat.ai/papers/10.3892/etm.2015.2179
- The paper
- ZHU, Y., LI, C., SUN, A., WANG, Y., & ZHOU, S. (2015). Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2015.2179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.